Advate (Antihemophilic factor [recombinant])

Overview
Advate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Advate can also be used for… read more

Adynovate (Antihemophilic factor [recombinant], PEGylated)

Overview
Adynovate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in adults and adolescents over the age of 12 with factor VIII deficiency due to hemophilia A. Adynovate… read more

Afstyla (Antihemophilic factor [recombinant], single chain)

Overview
Afstyla is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Afstyla can also be used for… read more

Alhemo (Concizumab-Mtci)

Overview
Alhemo is approved by the U.S. Food and Drug Administration (FDA) for the routine prophylaxis (prevention) of bleeding episodes in adults and children aged 12 years and older with hemophilia A (congenital factor…

Alphanate (Antihemophilic factor/von Willebrand factor complex [human])

Overview
Alphanate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Alphanate is also used in people… read more

AlphaNine SD (Coagulation factor IX [human])

Overview
AlphaNine SD is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of AlphaNine SD is Coagulation factor IX factor (human).… read more

Alprolix (Coagulation factor IX [recombinant], Fc fusion protein)

Overview
Alprolix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Alprolix can also be used for perioperative (before, during, and… read more

Altuviiio (Antihemophilic Factor [Recombinant], Fc-VWF-XTEN Fusion Protein-Ehtl)

Overview
Altuviiio is approved by the U.S. Food and Drug Administration (FDA) for use in adults and children with hemophilia A (congenital factor VIII deficiency). It is indicated for routine prophylaxis to reduce…

Amicar (Aminocaproic acid)

Overview
Amicar is approved by the Food and Drug Administration (FDA) to stop bleeding. Amicar may be used during heart surgery and for bleeding disorders such as hemophilia. Amicar is also known by its drug name,… read more

Bebulin (Factor IX complex [human])

Overview
Bebulin is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Bebulin is Factor IX complex (human).

Bebulin is a clotting… read more

BeneFix (Coagulation factor IX [recombinant])

Overview
BeneFix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. BeneFix can also be used for perioperative (before, during, and… read more

Central venous access devices

Overview
People with hemophilia who have developed inhibitors may need frequent or urgent doses of intravenous medications, especially while undergoing immune tolerance therapy. Some people choose to have a central… read more

Coagadex (Coagulation Factor X [Human])

Overview
Coagadex is approved by the U.S. Food and Drug Administration (FDA) for use in adults and children with hereditary factor X (10) deficiency. It is indicated for routine prophylaxis to reduce bleeding episodes…

Corifact (Factor XIII concentrate [human])

Overview
Corifact is approved by the Food and Drug Administration (FDA) for routine prophylaxis and perioperative (before, during, and after surgery) care in children and adults with congenital factor XIII deficiency.… read more

Cyklokapron (Tranexamic acid)

Overview
Cyklokapron is approved by the Food and Drug Administration (FDA) for short-term use in people with hemophilia. Cyklokapron may be used for two to eight days to reduce or prevent hemorrhage during and after… read more

DDAVP (Desmopressin Acetate)

Overview
DDAVP is approved by the U.S. Food and Drug Administration (FDA) for use in people with hemophilia A who have factor VIII (8) coagulant activity levels greater than 5 percent as well as for people with von…

Eloctate (Antihemophilic factor [recombinant], Fc fusion protein)

Overview
Eloctate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Eloctate can also be used for… read more

Esperoct (Antihemophilic factor [recombinant], glycopegylated-exei)

Overview
Esperoct is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in adults and children with factor VIII deficiency due to hemophilia A. Esperoct can also be used for… read more

Feiba (Anti-inhibitor coagulant complex)

Overview
Feiba is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in people with hemophilia A and B who have developed inhibitors. Feiba can also be used for perioperative (before,… read more

Helixate FS (Antihemophilic factor [recombinant], formulated with sucrose)

Overview
Helixate FS is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Helixate FS can also be used for perioperative (before,… read more

Hemgenix (Etranacogene dezaparvovec-drlb)

Overview
Hemgenix is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with hemophilia B. To be eligible for Hemgenix, you must either currently be using factor IX (9)… read more

Hemlibra (Emicizumab-kxwh)

Overview
Hemlibra is approved by the Food and Drug Administration (FDA) as routine prophylaxis in children and adults with hemophilia A and factor VIII inhibitors. The technical name of Hemlibra is Emicizumab-kxwh.… read more

Hemofil M (Antihemophilic factor [human], method M, monoclonal purified)

Overview
Hemofil M is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in people with factor VIII deficiency due to hemophilia A. The technical name of Hemofil M is… read more

Humate-P (Antihemophilic factor/von Willebrand factor complex [human])

Overview
Humate-P is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Humate-P is also used to treat bleeding episodes and for perioperative (before,… read more

Hympavzi (Marstacimab-Hncq)

Overview
Hympavzi is approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and children 12 and up with hemophilia A (congenital…

Idelvion (Coagulation factor IX [recombinant], albumin fusion protein)

Overview
Idelvion is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor IX deficiency due to hemophilia B. Idelvion can also be used for… read more

Immune tolerance therapy (ITT)

Overview
Immune tolerance therapy (ITT) involves infusing clotting factor concentrate in scheduled doses to train the body to tolerate the factor. The goal of ITT is to eradicate the inhibitor.

What does it involve?… read more

Ixinity (Coagulation factor IX [recombinant])

Overview
Ixinity is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults and children age 12 or older with hemophilia B. Ixinity can also be used for perioperative (before,… read more

Jivi (Antihemophilic Factor [Recombinant] Pegylated-Aucl)

Overview
Jivi is a recombinant antihemophilic factor approved by the U.S. Food and Drug Administration (FDA) for the treatment and management of hemophilia A (congenital factor VIII [8] deficiency) in previously treated…

Koate-DVI (Antihemophilic factor [human])

Overview
Koate-DVI is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Koate-DVI can also be used for perioperative (before, during, and after surgery)… read more

Kogenate FS (Antihemophilic factor [recombinant])

The Kogenate FS brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to… read more

Konyne 80 (Factor IX complex [human)

Overview
Konyne 80 is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Konyne 80 may also be used to reverse coumarin anticoagulant-induced hemorrhage and… read more

Kovaltry (Antihemophilic factor [recombinant])

Overview
Kovaltry is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Kovaltry can also be used for… read more

Monoclate P (Antihemophilic factor [human] factor VIII)

Overview Monoclate P is approved by the Food and Drug Administration (FDA) to control bleeding episodes and for perioperative (before, during, and after surgery) care in adults and children with factor VIII deficiency…

Mononine (Coagulation factor IX [human])

Overview
Mononine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Mononine is Coagulation factor IX factor (human).

Mononine… read more

Novoeight (Antihemophilic factor [recombinant])

Overview
Novoeight is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Novoeight can also be used for perioperative (before, during,… read more

NovoSeven RT (Coagulation factor VIIa [recombinant])

Overview
NovoSeven RT is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A or B. Typically, NovoSeven RT… read more

Nuwiq (Human coagulation factor VIII [rDNA], simoctocog alfa)

Overview
Nuwiq is approved by the Food and Drug Administration (FDA) to treat and prevent bleeding episodes in children and adults with hemophilia A (congenital factor VIII deficiency). The technical name of Nuwiq is… read more

Obizur (Antihemophilic factor [Recombinant], porcine sequence)

Overview
Obizur is approved by the Food and Drug Administration (FDA) to control bleeding episodes in adults with acquired hemophilia. The technical name of Obizur is Antihemophilic factor (recombinant), porcine… read more

Profilnine (Factor IX complex [human])

Overview
Profilnine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Profilnine is Factor IX complex (human).

Profilnine is a… read more

Proplex-T (Factor IX complex, heat treated [human])

Overview
Proplex-T is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Proplex-T may also be used for perioperative (before, during, and after surgery)… read more

Qfitlia (Fitusiran)

Overview

Qfitlia is a medication used to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with hemophilia A or B, with or without inhibitors to factor VIII or IX. It is approved by…

Rebinyn (Coagulation factor IX [recombinant], glycoPEGylated)

Overview Rebinyn is approved by the Food and Drug Administration (FDA) to treat bleeding episodes in adults and children with hemophilia B. Rebinyn can also be used for perioperative (before, during, and after surgery)…

Recombinate (Antihemophilic factor [recombinant])

Overview
Recombinate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Recombinate can also be used for perioperative (before,… read more

ReFacto (Antihemophilic factor [recombinant])

Overview
ReFacto is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. ReFacto can also be used for perioperative (before, during, and… read more

RiaSTAP (Fibrinogen concentrate [human])

Overview
RiaSTAP is approved by the Food and Drug Administration (FDA) to treat acute bleeding episodes in people with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. The technical… read more

Rixubis (Coagulation factor IX [recombinant])

Overview
Rixubis is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Rixubis can also be used for perioperative (before, during, and… read more

Roctavian (Valoctocogene roxaparvovec-rvox)

Overview
Roctavian is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with severe hemophilia A. Roctavian is also known by its drug name, valoctocogene… read more

Sevenfact (Coagulation Factor VIIa [Recombinant]-Jncw)

Overview
Sevenfact is approved by the U.S. Food and Drug Administration (FDA) for the treatment and control of bleeding episodes in adults and adolescents (12 years and older) who have hemophilia A or B with inhibitors…

Stimate (Desmopressin) for Hemophilia

Stimate Nasal Spray was voluntarily pulled from the U.S. market in July 2020.

The recall was issued after routine testing found the product contained higher-than-specified amounts of desmopressin, leading to a risk of…

Tretten (Coagulation factor XIII A-subunit [recombinant])

Overview Tretten is approved by the Food and Drug Administration (FDA) for routine prophylaxis in children and adults with congenital factor XIII A-subunit deficiency. The technical name of Tretten is Coagulation factor…

Vonvendi (von Willebrand factor [recombinant])

Overview
Vonvendi is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in adults with von Willebrand disease. The technical name of Vonvendi is von Willebrand… read more

Wilate (von Willebrand factor/Coagulation factor VIII complex [human])

Overview
Wilate is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in children and adults with von Willebrand disease. Wilate can also be used for… read more

Xyntha (Antihemophilic factor [recombinant])

Overview
Xyntha is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Xyntha can also be used for perioperative (before, during, and… read more